Racing

Caster Semenya ‘disappointed’ as she is now unable to defend his 800m world title

Caster Semenya the holder of the 800-meter world title is disappointed about the court ruling that she will now be unable to defend her title at the World Athletics Championships which are held next month in Doha.

 

The Swiss Supreme Court made a reversal on the ruling of the IAAF, the ruling governing body of the sport, related to the testosterone levels which are pending for the appeal by Semenya.

This ruling form the Supreme Court means that Semenya is now obligated to submit the medication for hormone-reduction, which is something she has refused for consideration as she intended to compete in the competition next month.

Semenya’s PR Company issued a statement from her, “I am very sorry that I am being kept by law from defending the title I earned with difficulty. Still, this is not going to stop me from continuing my own fight for the sake of human rights for all the female athletes.”

In an interview earlier this month with BBC, Semenya said that she feels as if she is being crucified for her fight against the IAAF’s rules related to the “Athletes with Differences of Sex Development”.

Back last month, Athletes with Differences of Sex Development was able to win the interim suspension of the rule by the Swiss Court but the ruling of the court was reversed after they found that the threshold of the suspension which is very high and was not met.

The layer named Dorothee Schramm, who is leading the appeal from the sprinter said, “The procedural decision from the judge has no impact on the appeal. We are going to continue fighting for her appeal and also fight for her basic human rights. A race is always the one that ends on a finish line.”

As for IAAF, the said in a statement, “We understand the Swiss Federal Tribunal will be issuing its full decision on this order tomorrow (Wednesday) and the IAAF will comment once the tribunal makes its reasoning public.”

Related Content

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top